ChromaDex Corporation is a nutraceutical company focused on promoting healthy aging through innovative ingredients and scientific research. It is best known for its flagship product, Nicotinamide riboside (NIAGEN), a form of vitamin B3 that helps enhance levels of nicotinamide adenine dinucleotide (NAD+), which naturally decline with age. The company also offers Immulina, a spirulina extract aimed at boosting immune function. ChromaDex operates through three primary segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the bulk of its revenue generated from the Consumer Products segment. The company is involved in developing and commercializing patented ingredient technologies for various markets, including dietary supplements, food, beverages, skincare, and pharmaceuticals. Alongside its product offerings, ChromaDex provides analytical testing and regulatory consulting services, reinforcing its commitment to quality and safety in its ingredient development. Headquartered in Los Angeles, California, ChromaDex continues to leverage its extensive intellectual property and scientific backing in the biosciences sector.